1762 — Chunghwa Chemical Synthesis & Biotech Co Balance Sheet
0.000.00%
Last trade - 00:00- TWD2.22bn
- TWD2.86bn
- TWD1.35bn
- 63
- 42
- 15
- 33
Annual balance sheet for Chunghwa Chemical Synthesis & Biotech Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 149 | 195 | 301 | 270 | 222 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 368 | 396 | 312 | 257 | 208 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 1,002 | 1,357 | 1,449 | 1,788 | 1,441 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,542 | 1,868 | 1,964 | 2,292 | 2,199 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 3,147 | 4,381 | 4,564 | 5,172 | 4,763 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 400 | 635 | 614 | 831 | 425 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 649 | 1,487 | 1,371 | 1,821 | 1,406 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 2,498 | 2,894 | 3,193 | 3,350 | 3,357 |
| Total Liabilities & Shareholders' Equity | 3,147 | 4,381 | 4,564 | 5,172 | 4,763 |
| Total Common Shares Outstanding |